CDNA vs MS · rev $333.8M vs P/E 20, $344.27B cap
CareDx Inc (CDNA) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
CareDx Inc (CDNA) is a diagnostics & research company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported CDNA revenue for 2024-12-31 was $333.8M. Net income was $52.5M. Revenue was up 19.1% from 2023-12-31 to 2024-12-31. CDNA currently screens at market cap $1.18B.
MS does not have a complete income-statement cache yet.
CDNA currently screens at market cap $1.18B. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the CDNA and MS stock pages for the full models.
Not investment advice.